Skip to main content
Top
Published in: BMC Neurology 1/2010

Open Access 01-12-2010 | Research article

Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria

Authors: Njideka U Okubadejo, Oluwadamilola O Ojo, Olajumoke O Oshinaike

Published in: BMC Neurology | Issue 1/2010

Login to get access

Abstract

Background

Current data on the pattern of parkinsonism and Parkinson's disease in Nigerians are sparse.
This database was designed to document the clinical profile of PD in Nigerians, and compare this to prior observations.

Methods

A database of patients presenting to the Neurology out-patients clinic of the Lagos University Teaching Hospital was established in October 1996. Demographic and clinical data at presentation (disease stage using Hoehn and Yahr scale; 'off' state severity on the Unified Parkinson's disease Rating Scale) were documented for patients diagnosed with parkinsonism between October 1996 and December 2006. Cases were classified as Parkinson's disease or secondary parkinsonism (in the presence of criteria suggestive of a secondary aetiology).

Results

The hospital frequency of parkinsonism (over a 2-year period, and relative to other neurologic disorders) was 1.47% (i.e. 20/1360). Of the 124 patients with parkinsonism, 98 (79.0%) had PD, while 26 (21.0%) had secondary parkinsonism. Mean age (SD) at onset of PD (61.5 (10.0) years) was slightly higher than for secondary parkinsonism (57.5 (14.0) years) (P = 0.10). There was a male preponderance in PD (3.3 to 1) and secondary parkinsonism (2.7 to 1), while a positive family history of parkinsonism was present in only 1.02% (1/98) of PD. There was a modestly significant difference in age at onset (SD) of PD in men (60.3 (10.4)) compared to women (65.2 (7.9)) (T = 2.08; P = 0.04). The frequency of young onset PD (≤ 50 years) was 16.3% (16/98). The mean time interval from onset of motor symptoms to diagnosis of PD was 24.6 ± 26.1 months with majority presenting at a median 12 months from onset. On the H&Y scale, severity of PD at presentation was a median 2.0 (range 1 to 4). PD disease subtype was tremor-dominant in 31 (31.6%), mixed 54 (55.1%) and akinetic-rigid 14 (14.3%). Hypertension was present as a co-morbidity in 20 (20.4%), and diabetes in 6 (6.12%).

Conclusions

The clinical profile of PD in Nigerians is similar to that in other populations, but is characterized by delayed presentation as has been reported in other developing countries. Young-onset disease occurs but may be less commonly encountered, and frequency of a positive family history is lower than in western populations.
Literature
1.
go back to reference Okubadejo NU, Bower JH, Rocca WA, Maraganore DM: Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies. Mov Disord. 2006, 12: 2150-2156. 10.1002/mds.21153.CrossRef Okubadejo NU, Bower JH, Rocca WA, Maraganore DM: Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies. Mov Disord. 2006, 12: 2150-2156. 10.1002/mds.21153.CrossRef
2.
go back to reference Osuntokun BO, Schoenberg BS, Nottidge VA, Adeuja A, Kale O, Adeyefa A, Bademosi O, Olumide A, Oyediran ABO, Pearson CA, Bolis CL: Research protocol for measuring the prevalence of neurologic disorders in developing countries: results of a pilot study in Nigeria. Neuroepidemiology. 1982, 1: 143-153. 10.1159/000110696.CrossRef Osuntokun BO, Schoenberg BS, Nottidge VA, Adeuja A, Kale O, Adeyefa A, Bademosi O, Olumide A, Oyediran ABO, Pearson CA, Bolis CL: Research protocol for measuring the prevalence of neurologic disorders in developing countries: results of a pilot study in Nigeria. Neuroepidemiology. 1982, 1: 143-153. 10.1159/000110696.CrossRef
3.
go back to reference Osuntokun BO, Adeuja AO, Schoenberg BS, Bademosi O, Nottidge VA, Olumide AO, Ige O, Yaria F, Bolis CL: Neurological disorders in Nigerian Africans: a community-based study. Acta Neurol Scand. 1987, 75: 13-21. 10.1111/j.1600-0404.1987.tb07883.x.CrossRefPubMed Osuntokun BO, Adeuja AO, Schoenberg BS, Bademosi O, Nottidge VA, Olumide AO, Ige O, Yaria F, Bolis CL: Neurological disorders in Nigerian Africans: a community-based study. Acta Neurol Scand. 1987, 75: 13-21. 10.1111/j.1600-0404.1987.tb07883.x.CrossRefPubMed
4.
go back to reference Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW, Haerer AF: Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology. 1988, 38: 645-646.CrossRefPubMed Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW, Haerer AF: Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology. 1988, 38: 645-646.CrossRefPubMed
5.
go back to reference Osuntokun BO, Bademosi O: Parkinsonism in the Nigerian African: a prospective study of 217 patients. East Afr Med J. 1979, 56: 597-607.PubMed Osuntokun BO, Bademosi O: Parkinsonism in the Nigerian African: a prospective study of 217 patients. East Afr Med J. 1979, 56: 597-607.PubMed
6.
go back to reference Quinn N: Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry. 1989, 52: 78-89. 10.1136/jnnp.52.Suppl.78.CrossRefPubMedCentral Quinn N: Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry. 1989, 52: 78-89. 10.1136/jnnp.52.Suppl.78.CrossRefPubMedCentral
7.
go back to reference Ahlskog JE: Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism. Parkinsonism and Related Disorders. 2001, 7: 63-70. 10.1016/S1353-8020(00)00047-X.CrossRef Ahlskog JE: Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism. Parkinsonism and Related Disorders. 2001, 7: 63-70. 10.1016/S1353-8020(00)00047-X.CrossRef
8.
go back to reference Schrag A, Ben-Shlomo Y, Quinn N: How valid is the clinical diagnosis of Parkinson's disease in the community?. J Neurol Neurosurg Psychiatry. 2002, 73: 529-534. 10.1136/jnnp.73.5.529.CrossRefPubMedPubMedCentral Schrag A, Ben-Shlomo Y, Quinn N: How valid is the clinical diagnosis of Parkinson's disease in the community?. J Neurol Neurosurg Psychiatry. 2002, 73: 529-534. 10.1136/jnnp.73.5.529.CrossRefPubMedPubMedCentral
9.
10.
go back to reference Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease: Movement Disorder Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004, 19: 1020-1028. 10.1002/mds.20213.CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L, Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease: Movement Disorder Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004, 19: 1020-1028. 10.1002/mds.20213.CrossRefPubMed
11.
go back to reference Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease: The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003, 18: 738-50. 10.1002/mds.10473.CrossRef Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease: The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003, 18: 738-50. 10.1002/mds.10473.CrossRef
12.
go back to reference Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988, 51: 745-52. 10.1136/jnnp.51.6.745.CrossRefPubMedPubMedCentral Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988, 51: 745-52. 10.1136/jnnp.51.6.745.CrossRefPubMedPubMedCentral
13.
go back to reference Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ, Quality Standards Subcommittee of the American Academy of Neurology: Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006, 66: 968-75. 10.1212/01.wnl.0000215437.80053.d0.CrossRefPubMed Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ, Quality Standards Subcommittee of the American Academy of Neurology: Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006, 66: 968-75. 10.1212/01.wnl.0000215437.80053.d0.CrossRefPubMed
14.
go back to reference Alvarez MV, Evidente VG, Driver-Dunckley ED: Differentiating Parkinson's disease from other parkinsonian disorders. Semin Neurol. 2007, 27: 356-62. 10.1055/s-2007-985336.CrossRefPubMed Alvarez MV, Evidente VG, Driver-Dunckley ED: Differentiating Parkinson's disease from other parkinsonian disorders. Semin Neurol. 2007, 27: 356-62. 10.1055/s-2007-985336.CrossRefPubMed
15.
go back to reference Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology. 1999, 52: 1214-20.CrossRefPubMed Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology. 1999, 52: 1214-20.CrossRefPubMed
16.
go back to reference Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L, Inzitari D: Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology. 2000, 55: 1358-1363.CrossRefPubMed Baldereschi M, Di Carlo A, Rocca WA, Vanni P, Maggi S, Perissinotto E, Grigoletto F, Amaducci L, Inzitari D: Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology. 2000, 55: 1358-1363.CrossRefPubMed
17.
go back to reference Dluzen DF: Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J Neurocytol. 2000, 29: 387-99. 10.1023/A:1007117424491.CrossRefPubMed Dluzen DF: Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J Neurocytol. 2000, 29: 387-99. 10.1023/A:1007117424491.CrossRefPubMed
18.
go back to reference Pankratz N, Foroud T: Genetics of Parkinson disease. Genet Med. 2007, 9: 801-11. 10.1097/GIM.0b013e31815bf97c.CrossRefPubMed Pankratz N, Foroud T: Genetics of Parkinson disease. Genet Med. 2007, 9: 801-11. 10.1097/GIM.0b013e31815bf97c.CrossRefPubMed
19.
go back to reference Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, Vieregge P, Wüllner U, Gasser T: Genes associated with Parkinson syndrome. J Neurol. 2008, 255 (Suppl 5): 8-17. 10.1007/s00415-008-5005-2.CrossRefPubMed Biskup S, Gerlach M, Kupsch A, Reichmann H, Riederer P, Vieregge P, Wüllner U, Gasser T: Genes associated with Parkinson syndrome. J Neurol. 2008, 255 (Suppl 5): 8-17. 10.1007/s00415-008-5005-2.CrossRefPubMed
20.
go back to reference Okubadejo N, Britton A, Crews C, Akinyemi R, Hardy J, Singleton A, Bras J: Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3. PLoS ONE. 2008, 3: e3421-10.1371/journal.pone.0003421.CrossRefPubMedPubMedCentral Okubadejo N, Britton A, Crews C, Akinyemi R, Hardy J, Singleton A, Bras J: Analysis of Nigerians with apparently sporadic Parkinson disease for mutations in LRRK2, PRKN and ATXN3. PLoS ONE. 2008, 3: e3421-10.1371/journal.pone.0003421.CrossRefPubMedPubMedCentral
21.
go back to reference Dotchin CL, Msuya O, Walker RW: The challenge of Parkinson's disease management in Africa. Age Ageing. 2007, 36: 122-7. 10.1093/ageing/afl172.CrossRefPubMed Dotchin CL, Msuya O, Walker RW: The challenge of Parkinson's disease management in Africa. Age Ageing. 2007, 36: 122-7. 10.1093/ageing/afl172.CrossRefPubMed
22.
go back to reference Okubadejo NU, Ojini FI, Danesi MA: Longitudinal study of mortality predictors in Parkinson's disease in Nigerians. African Journal of Medicine and Medical Sciences. 2005, 34: 365-9.PubMed Okubadejo NU, Ojini FI, Danesi MA: Longitudinal study of mortality predictors in Parkinson's disease in Nigerians. African Journal of Medicine and Medical Sciences. 2005, 34: 365-9.PubMed
Metadata
Title
Clinical profile of parkinsonism and Parkinson's disease in Lagos, Southwestern Nigeria
Authors
Njideka U Okubadejo
Oluwadamilola O Ojo
Olajumoke O Oshinaike
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2010
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/1471-2377-10-1

Other articles of this Issue 1/2010

BMC Neurology 1/2010 Go to the issue